NUWE
Nuwellis Inc
NASDAQ: NUWE · HEALTHCARE · MEDICAL DEVICES
$5.66
+4.62% today
Updated 2026-10-28
Market cap
$1.17M
P/E ratio
0.00
P/S ratio
0.13x
EPS (TTM)
$435.92
Dividend yield
—
52W range
$0 – $173
Volume
2.5M
Nuwellis Inc (NUWE) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.66
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$18.91
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -125.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.